No. Our team of experts handles the implementation, training, and ongoing support, ensuring your staff can easily adopt and benefit from AI without needing deep technical expertise.

Yes. AI analyses genomic, clinical, and patient data to tailor treatments, improving outcomes and supporting precision medicine initiatives.

We implement strict data governance, encryption, and access controls to ensure that all sensitive information remains secure and confidential.

Absolutely. AI can identify promising drug candidates faster, optimise trial designs, and automate reporting, significantly reducing research and operational costs.

All pharmaceutical and biotech companies, from startups to global enterprises, can leverage AI to accelerate research, optimise trials, and improve operational efficiency.

Results vary depending on data availability and project scope, but many companies see measurable improvements within 3–6 months of implementing AI solutions.

While more data improves AI accuracy, even smaller datasets can be used effectively through advanced models, data augmentation, and integration with external sources.

Yes. 3Point AI ensures all solutions adhere to relevant industry standards, including GDPR, HIPAA, and FDA requirements for clinical and patient data.